Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (1.235%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.15
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues flash on Agronomics (ANIC)

26 Sep 2022 08:48

RNS Number : 6052A
Agronomics Limited
26 September 2022
 

London, UK, 26 September 2022

 

Edison issues flash on Agronomics (ANIC)

Agronomics (ANIC) invests in cellular agriculture companies. In our last note, we discussed a shift in its focus more towards precision fermentation companies, whose development is more advanced, offering greater near-term commercial potential. This week's announcement that Onego Bio, one of ANIC's portfolio companies, has entered a partnership with Perfect Day, a US precision fermentation company, is a further step in this direction. The alliance should hasten Onegro Bio's route to market and financial viability and increase ANIC's potential to realise further NAV uplifts. Food giant Nestlé's recent move into precision fermentation is further evidence that ANIC's increasing interest in this sector may prove timely.

 

News of Onego Bio's alliance with Perfect Day closely follows another announcement that bodes well for the future of precision fermentation technology more generally, and for ANIC's increasing investment in this sector. Last week, Nestlé announced it is exploring emerging technologies for the development of animal-free dairy protein-based products. Nestlé's interest in fermentation technology demonstrates the attraction this technology has as a potentially viable method of producing animal-free protein at scale. Specifically, Nestlé will pilot a novel product that uses animal-free protein produced by Perfect Day. The product will be tested in the US market later this year. Further details about this product are not yet available, but its development will be supported by Nestlé's R&D Accelerator programme, which brings together start-ups, academic institutions and Nestlé scientists with the purpose of accelerating the development of new products and systems. Programme participants have access to Nestlé's R&D expertise and its infrastructure, including labs, kitchens and pilot-scale equipment. 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Joanne Collins +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Sara Welford +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUACBUPPUMQ
Date   Source Headline
9th Dec 20207:00 amRNSInvestment in CellX
7th Dec 20201:00 pmRNSPortfolio Update: Mosa Meat
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO
1st Apr 20207:00 amRNSFurther investment in Rebellyous Foods
31st Mar 202010:56 amRNSSubscription of US$2,999,996 in Tropic Biosciences
13th Mar 20207:00 amRNSPortfolio Company Update: Foods United
10th Mar 20207:00 amRNSInvestment of US$ 500,000 in GALY CO.
27th Feb 20207:00 amRNSPortfolio Company BlueNalu Announces Financing
13th Feb 20207:00 amRNSAdditional Investment of US$1 Million in VitroLabs
12th Feb 20207:00 amRNSInvestment of US$3million in Foods United
4th Feb 20201:04 pmRNSResult of AGM
31st Jan 20204:42 pmRNSHolding(s) in Company
28th Jan 20203:58 pmRNSHolding(s) in Company
24th Jan 20201:00 pmRNSFurther Equity Fundraise of £5.5 million
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSHalf-year Report
27th Dec 201912:30 pmRNSIssue of Equity
20th Dec 20197:00 amRNSInvestment in Meatable BV
19th Dec 20197:00 amRNSAdditional Participation in BlueNalu Fundraise
18th Dec 20197:00 amRNSInvestment in LegenDairy Foods GmbH
16th Dec 20194:02 pmRNSHolding(s) in Company
16th Dec 20193:33 pmRNSHolding(s) in Company
12th Dec 20196:01 pmRNSHolding(s) in Company
11th Dec 201912:00 pmRNSInvestment in Oritain Global Limited
9th Dec 20193:00 pmRNSEquity Fundraise Closes at £7.7 million
6th Dec 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.